Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3406 publications
Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Dicerna Pharmaceuticals, Inc.’s pipeline products Reasons to ...

Jul, 2014 27 pages
Dermatologicals in Hong Kong, China US$ 900.00

... the end of the review period. Consequently,... Euromonitor International's Dermatologicals in Hong Kong, China report offers a comprehensive guide to the size and ... data. Why buy this report? Get a detailed picture of the Dermatologicals market; Pinpoint growth sectors and identify factors driving change ...

Jul, 2014 23 pages
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market US$ 3,500.00

... business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four ... market entry and expansion strategies by identifying the regions and therapeutic segments poised for strong growth Devise effective, tailored strategies ...

Jul, 2014 72 pages
Global Hormone Replacement Therapy Market 2014-2018 US$ 2,500.00

... that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal ... , and bowel cancer. TechNavio's analysts forecast the Global Hormone Replacement Therapy market will grow at a CAGR of 2.51 percent over the period ...

Jul, 2014 87 pages
FluGen, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the FluGen, Inc.’s pipeline products ... drug targets and therapeutic classes in the FluGen, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 20 pages
Bluebird bio, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the bluebird bio, Inc.’s pipeline products REASONS ...

Jul, 2014 27 pages
Sotio a.s. - Product Pipeline Review - 2014 US$ 1,500.00

... - 2014 Summary Global Markets Direct’s, ‘Sotio a.s. - Product Pipeline Review - 2014’, provides an overview of the Sotio a.s.’s pharmaceutical research and development focus ... and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key ...

Jun, 2014 23 pages
Senhwa Biosciences, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Senhwa Biosciences’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Senhwa Biosciences’s pipeline products ...

Jun, 2014 28 pages
Pharmedartis GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pharmedartis GmbH’s pipeline products ... areas of focus Identify new drug targets and therapeutic classes in the Pharmedartis GmbH’s R&D portfolio and develop key strategic initiatives to reinforce ...

Jun, 2014 25 pages
Opioid Induced Side Effects - Pipeline Review, H1 2014 US$ 2,000.00

... , H1 2014’, provides an overview of the Opioid Induced Side Effects’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... Induced Side Effects The report reviews key pipeline products under drug profile section which includes, product description, MoA and ...

Jun, 2014 41 pages
Liposarcoma - Pipeline Review, H1 2014 US$ 2,000.00

... - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at ...

Jun, 2014 65 pages
InvivoGen Therapeutics - Product Pipeline Review - 2014 US$ 1,500.00

... of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the InvivoGen Therapeutics’s pipeline products ...

Jun, 2014 24 pages
GenSight Biologics - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of GenSight Biologics’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the GenSight Biologics’s pipeline products ...

Jun, 2014 23 pages
Contraception - Pipeline Review, H1 2014 US$ 2,000.00

... - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Contraception - Pipeline Review, H1 2014’, provides an overview of the Contraception’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Contraception, complete with comparative analysis at ...

Jun, 2014 103 pages
Burkholderia Infections - Pipeline Review, H1 2014 US$ 2,000.00

Burkholderia Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H1 2014’, provides an overview of the Burkholderia Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ...

Jun, 2014 32 pages
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 US$ 2,500.00

... tomography (CT), and biopsy tests. TechNavio's analysts forecast the Global Non-Hodgkin Lymphoma Therapeutics market will grow at a CAGR of 7.03 percent over the ... report also includes a discussion of the key vendors operating in this market. KEY REGIONS Americas EMEA APAC KEY VENDORS Bristol Myers ...

Jun, 2014 91 pages
2013 Sales of Recombinant Therapeutic Antibodies & Proteins US$ 68.00

2013 Sales of Recombinant Therapeutic Antibodies Proteins This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2013. Sales data were obtained from company publications ...

Mar, 2014 37 pages
2014 Market Research Report on Global Radiotherapy Simulator Industry US$ 2,850.00

'2014 Market Research Report on Global Radiotherapy Simulator Industry' was a professional and depth research report on Global Radiotherapy Simulator industry that ... from Radiotherapy Simulator industry chain related technical experts and marketing experts during Research Team survey and interviews. The report ...

Jun, 2014 176 pages
Physician Views: What does the future hold for new EGFR targeting NSCLC therapies? US$ 645.00

... status – will be presented at next year's ASCO meeting. To gain better physician insight on the potential future role of these two therapies, FirstWord ... 1686 ahead of current EGFR therapies such as Tarceva based on current data? What progression-free survival (PFS) benefit CO-1686 would have to demonstrate ...

Jun, 2014
Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019) US$ 800.00

The report titled “Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global aortic aneurysm repair market ... which can lead to serious complications as it weakens the walls of the aorta. An aneurysm can develop anywhere along aorta but it mostly occurs in the ...

Jun, 2014 70 pages
Cancer Cell Therapy Market & Pipeline Insight US$ 2,400.00

... to heal previously irreparable tissues. With their rising popularity, these therapies are becoming more cost effective and efficient.The discovery ... be in a better position to develop efficient drugs and prevent the spread of cancer.“Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: ...

Jun, 2014 195 pages
Physician Views: Can new biologic therapies expand the severe asthma market? US$ 645.00

... are eligible for treatment with either currently available or future biologic therapies (including non-refractory patients if necessary)? Whether they would ... will be more important than secondary efficacy measures for differentiating new biologic therapies for severe asthma? What level of advantage, if any ...

Jun, 2014
Physician Views: Are neurologists ready to embrace gene therapy? US$ 645.00

... polling US and EU-5 based neurologists to ascertain how practising physicians currently view and evaluate the gene therapy development space. Specifically we are asking ... therapy What they perceive to be the key benefits of gene therapy? What are their specific concerns with gene therapy? What is the highest ...

Jun, 2014
Global Proton Therapy Outlook 2018 US$ 2,000.00

... centers that have been established globally. According to our report, “Global Proton Therapy Outlook 2018”, 16 such centers have been established ... capacity of existing centers and those that are expected to come up by 2018. In the Geographic Assessment section, we have provided a detailed analysis of four ...

Jun, 2014 90 pages
Arterial Thrombosis - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2014’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline. This report provides ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

May, 2014 47 pages
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) clinical trial scenario. This report provides elemental information and data ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

May, 2014 86 pages
Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... (Maroteaux-Lamy Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ...

May, 2014 71 pages
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... 's clinical trial report, “Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) Global Clinical Trials Review, H1, 2014' provides data on the Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on ...

May, 2014 111 pages
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... elemental information and data relating to the clinical trials on Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome). It includes an overview of the trial numbers and ... of trials for the key drugs for treating Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome). This report is built using data and ...

May, 2014 64 pages
OpportunityAnalyzer: Gout - Opportunity Analysis and Forecast to 2018 US$ 5,995.00

... number of patients for whom the standard therapies are inappropriate. Gout market is still marked by the presence of a number of unmet needs in current ... , clinical trial mapping and implications for the gout therapeutics market. Pipeline analysis: comprehensive data split across different phases, emerging ...

Apr, 2014 181 pages
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) clinical trial scenario. This report provides elemental information and data ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

May, 2014 74 pages
Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Mixed Dyslipidemia. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

May, 2014 123 pages
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H1 2014 US$ 2,000.00

... Aureus Infection (VRSA) - Pipeline Review, H1 2014’, provides an overview of the Vancomycin Resistant Staphylococcus Aureus Infection (VRSA)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vancomycin Resistant Staphylococcus Aureus Infection (VRSA), ...

May, 2014 44 pages
Epstein-Barr Viral Infections - Pipeline Review, H1 2014 US$ 2,000.00

... , H1 2014’, provides an overview of the Epstein-Barr Viral Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

May, 2014 53 pages
Bacillus Anthracis Infections - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Bacillus Anthracis Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... for Bacillus Anthracis Infections and enlists all their major and minor projects The report summarizes all the dormant and ...

May, 2014 48 pages
US Proton Therapy Outlook: Market Opportunities US$ 2,000.00

... make it more accessible to patients. According to the “US Proton Therapy Outlook: Market Opportunities” by RNCOS, the United States will be home to almost 29 such centers ... size and its future condition. After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which ...

May, 2014 70 pages
Global Diabetic Neuropathy Market 2014-2018 US$ 2,500.00

... the key trends that are emerging in the market. TechNavio's report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on ... Global Diabetic Population. For a full, detailed list, view our report. Key Market Challenge High Failure Rate in Clinical Trials. For a full, detailed list, ...

May, 2014 55 pages
Streptococcus Pyogenes Infections - Pipeline Review, H1 2014 US$ 2,000.00

... Direct’s, ‘Streptococcus Pyogenes Infections - Pipeline Review, H1 2014’, provides an overview of the Streptococcus Pyogenes Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Streptococcus Pyogenes Infections, complete with comparative ...

Apr, 2014 32 pages
Infections Caused By Picornaviridae - Pipeline Review, H1 2014 US$ 2,000.00

... Direct’s, ‘Infections Caused By Picornaviridae - Pipeline Review, H1 2014’, provides an overview of the Infections Caused By Picornaviridae’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative ...

Apr, 2014 36 pages
Hypogonadotropic Hypogonadism - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Hypogonadotropic Hypogonadism - Pipeline Review, H1 2014’, provides an overview of the Hypogonadotropic Hypogonadism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hypogonadotropic Hypogonadism, complete with ...

Apr, 2014 58 pages
Bone Regeneration - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Bone Regeneration - Pipeline Review, H1 2014’, provides an overview of the Bone Regeneration’s therapeutic pipeline. This report provides ... key players involved in the therapeutics development for Bone Regeneration and enlists all their major and minor projects The report ...

Apr, 2014 40 pages
Axillary Hyperhidrosis - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Axillary Hyperhidrosis - Pipeline Review, H1 2014’, provides an overview of the Axillary Hyperhidrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Axillary Hyperhidrosis, complete with comparative analysis at ...

Apr, 2014 36 pages
Amyloidosis Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... 2014 SUMMARY GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2014' provides data on the Amyloidosis clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

May, 2014 110 pages
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Addison’s Disease (Primary or Chronic Adrenal Insufficiency) clinical trial scenario. This report provides elemental information ... . SCOPE Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and ...

May, 2014 71 pages
Polycystic Ovarian Syndrome - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Apr, 2014 48 pages
Lyme Disease - Pipeline Review, H1 2014 US$ 2,000.00

... Summary Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H1 2014’, provides an overview of the Lyme Disease’s therapeutic pipeline. This report provides ... & other developmental activities The report reviews key players involved in the therapeutics development for Lyme Disease and enlists all their ...

Apr, 2014 42 pages
Ebola Viral Infections - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Ebola Viral Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Apr, 2014 70 pages
Dystonia - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Dystonia - Pipeline Review, H1 2014’, provides an overview of the Dystonia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dystonia, complete with comparative analysis at various stages, therapeutics assessment by ...

Apr, 2014 48 pages
Metabolic Syndrome - Pipeline Review, H1 2014 US$ 2,000.00

Summary Global Markets Direct’s, ‘Metabolic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Metabolic Syndrome’s therapeutic pipeline. This report provides ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Mar, 2014 95 pages
Actinic (Solar) Keratosis - Pipeline Review, H1 2014 US$ 2,000.00

... Review, H1 2014’, provides an overview of the Actinic (Solar) Keratosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Mar, 2014 89 pages
1 2 3 4 5 >
Skip to top